Our work is the first to give an overview of the relationship between single-nucleotide polymorphisms in proinflammatory cytokines (IL-1, -6, -8, -15, -17, -18, -23, TNF-α) genes and RA susceptibility, severity, and patient’s response to applied treatment. The gene discussed is TNF; the disease is rheumatoid arthritis.